Study Design and Protocol for a Randomized Controlled Trial of Enavogliflozin to Evaluate Cardiorenal Outcomes in Type 2 Diabetes (ENVELOP)
Diabetes & metabolism journal(2025)
Key words
cardiovascular diseases,diabetes mellitus, type 2,enavogliflozin,kidney diseases,randomized controlled trial,sodium-glucose transporter 2 inhibitors
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined